Nick Conley
Vice President of Technology
@
Locus Biosciences
xr0j.6j0p0w@zj6ardx6a.1ha
Sign up to see email
Known information
- Co-founded EpiBiome, a venture-backed biotech company
- Developed the platform phage manufacturing process for the world's first clinical trial testing a recombinant bacteriophage therapy
- Earned a PhD in Chemistry from Stanford University
- Completed a postdoc in developmental biology at Stanford University
About Locus Biosciences
Locus Biosciences is a biotechnology company focused on developing precision medicines to combat antimicrobial resistance and treat microbiome-related diseases, utilizing CRISPR-engineered bacteriophage therapies and a robust biopharmaceutical development platform.